Latest News

President talks with RNZ on revised Pharmac criteria to give earlier access to medication.

June 29, 2022 | Advocacy, Media

Listen to MSNZ President, Neil Woodhams talk with RNZ presenters on the afternoon show ‘The Panel’. Hear him discuss the impacts Pharmac’s revised criteria for people with MS accessing medication earlier than ever before will have on people with MS […]


Media Release: The Economic Burden Report

June 15, 2022 | Media

Information Release: 8th June 2022 NZIER report: Earlier intervention of Multiple Sclerosis will benefit people with MS and the New Zealand economy A recently released report by the New Zealand Institute of Economic Research (NZIER), commissioned by the Multiple Sclerosis […]


More funded medicines for New Zealanders?

May 23, 2022 | Media, Treatments

Media article: 19 May 2022 Pharmac welcomes the $191 million increase to its pharmaceutical budget over the next two years. It is already working its way through the medicines options for investment (OFI) list, looking at what agreements it can […]


People with Multiple Sclerosis unable to access ‘life-changing treatment’ in NZ

May 9, 2022 | Advocacy, Life with MS, Media, My Story, Treatments

Published in Stuff on 5th May 2022 https://www.stuff.co.nz/national/health/128482766/people-with-multiple-sclerosis-unable-to-access-lifechanging-treatment-in-nz  


Media Release – Kiwis with MS ‘light years’ behind Aussie patients in treatment access and quality of life – study.

September 14, 2021 | Advocacy, Media, Study, Uncategorised

Media Release: 14 September 2021 (For Immediate Release) A new trans-Tasman study has highlighted alarming health inequities between New Zealand patients living with multiple sclerosis (MS) and their Australian counterparts — adding fuel to the ongoing fight for Pharmac to […]